title: [Effect of Signopam (Polfa) on clinical picture and thyroid function in patients with hyperthyroidism and euthyroidism].
authors.forename: M
authors.initials: M
authors.lastname: Mielnik-Kamm
authors.forename: K
authors.initials: K
authors.lastname: Pilarska
authors.forename: L
authors.initials: L
authors.lastname: Zalewska-Kubicka
authors.forename: S
authors.initials: S
authors.lastname: Tustanowski
mesh_terms: D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D013693:Temazepam / Q000627:therapeutic use*; D013961:Thyroid Gland / Q000187:drug effects* / Q000503:physiopathology
chemical_list: D014151:Anti-Anxiety Agents; D013693:Temazepam
vernacular_title: Wpływ Signopamu "Polfa" na obraz kliniczny i badania czynnościowe tarczycy u chorych z nadczynnościa tarczycy i osób z eutyreoza.